NCT00052624 2018-05-15
Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma
National Cancer Institute (NCI)
Phase 1 Unknown
Clinical Trials
3 trialsNCT00088400 2016-09-22
Comparison of TransMID vs Standard Treatment of Cancerous Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00083447 2009-01-07
Study of Therapy With TransMIDâ„¢ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
Xenova Biomedix
Phase 3 Withdrawn